期刊文献+
共找到3,137篇文章
< 1 2 157 >
每页显示 20 50 100
In vivo imaging reveals a synchronized correlation among neurotransmitter dynamics during propofol and sevoflurane anesthesia 被引量:1
1
作者 Gao-Lin Qiu Li-Jun Peng +6 位作者 Peng Wang Zhi-Lai Yang Ji-Qian Zhang Hu Liu Xiao-Na Zhu Jin Rao Xue-Sheng Liu 《Zoological Research》 SCIE CSCD 2024年第3期679-690,共12页
General anesthesia is widely applied in clinical practice.However,the precise mechanism of loss of consciousness induced by general anesthetics remains unknown.Here,we measured the dynamics of five neurotransmitters,i... General anesthesia is widely applied in clinical practice.However,the precise mechanism of loss of consciousness induced by general anesthetics remains unknown.Here,we measured the dynamics of five neurotransmitters,includingγ-aminobutyric acid,glutamate,norepinephrine,acetylcholine,and dopamine,in the medial prefrontal cortex and primary visual cortex of C57BL/6 mice through in vivo fiber photometry and genetically encoded neurotransmitter sensors under anesthesia to reveal the mechanism of general anesthesia from a neurotransmitter perspective.Results revealed that the concentrations of γ-aminobutyric acid,glutamate,norepinephrine,and acetylcholine increased in the cortex during propofol-induced loss of consciousness.Dopamine levels did not change following the hypnotic dose of propofol but increased significantly following surgical doses of propofol anesthesia.Notably,the concentrations of the five neurotransmitters generally decreased during sevoflurane-induced loss of consciousness.Furthermore,the neurotransmitter dynamic networks were not synchronized in the non-anesthesia groups but were highly synchronized in the anesthetic groups.These findings suggest that neurotransmitter dynamic network synchronization may cause anesthetic-induced loss of consciousness. 展开更多
关键词 General anesthesia Loss of consciousness In vivo neurotransmitter imaging Medial prefrontal cortex Primary visual cortex
下载PDF
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson's disease
2
作者 Xi Chen Yuhu Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第2期324-330,共7页
The dichotomized brain system is a concept that was generalized from the‘dual syndrome hypothesis’to explain the heterogeneity of cognitive impairment,in which anterior and posterior brain systems are independent bu... The dichotomized brain system is a concept that was generalized from the‘dual syndrome hypothesis’to explain the heterogeneity of cognitive impairment,in which anterior and posterior brain systems are independent but partially overlap.The dopaminergic system acts on the anterior brain and is responsible for executive function,working memory,and planning.In contrast,the cholinergic system acts on the posterior brain and is responsible for semantic fluency and visuospatial function.Evidence from dopaminergic/cholinergic imaging or functional neuroimaging has shed significant insight relating to the involvement of the cerebellum in the cognitive process of patients with Parkinson’s disease.Previous research has reported evidence that the cerebellum receives both dopaminergic and cholinergic projections.However,whether these two neurotransmitter systems are associated with cognitive function has yet to be fully elucidated.Furthermore,the precise role of the cerebellum in patients with Parkinson’s disease and cognitive impairment remains unclear.Therefore,in this review,we summarize the cerebellar dopaminergic and cholinergic projections and their relationships with cognition,as reported by previous studies,and investigated the role of the cerebellum in patients with Parkinson’s disease and cognitive impairment,as determined by functional neuroimaging.Our findings will help us to understand the role of the cerebellum in the mechanisms underlying cognitive impairment in Parkinson’s disease. 展开更多
关键词 anterior brain system CEREBELLUM CHOLINERGIC cognitive impairment DOPAMINERGIC dual syndrome hypothesis neuroimage neurotransmitter Parkinson’s disease posterior brain system therapeutic targets
下载PDF
Correlation between cerebral neurotransmitters levels by proton magnetic resonance spectroscopy and HbA1c in patients with type 2 diabetes
3
作者 Xiang-Yu Gao Chen-Xia Zhou +5 位作者 Hong-Mei Li Min Cheng Da Chen Zi-Yi Li Bo Feng Jun Song 《World Journal of Diabetes》 SCIE 2024年第6期1263-1271,共9页
BACKGROUND Cognitive dysfunction is the main manifestation of central neuropathy.Although cognitive impairments tend to be overlooked in patients with diabetes mellitus(DM),there is a growing body of evidence linking ... BACKGROUND Cognitive dysfunction is the main manifestation of central neuropathy.Although cognitive impairments tend to be overlooked in patients with diabetes mellitus(DM),there is a growing body of evidence linking DM to cognitive dysfunction.Hyperglycemia is closely related to neurological abnormalities,while often disregarded in clinical practice.Changes in cerebral neurotransmitter levels are associated with a variety of neurological abnormalities and may be closely related to blood glucose control in patients with type 2 DM(T2DM).AIM To evaluate the concentrations of cerebral neurotransmitters in T2DM patients exhibiting different hemoglobin A1c(HbA1c)levels.METHODS A total of 130 T2DM patients were enrolled at the Department of Endocrinology of Shanghai East Hospital.The participants were divided into four groups according to their HbA1c levels using the interquartile method,namely Q1(<7.875%),Q2(7.875%-9.050%),Q3(9.050%-11.200%)and Q4(≥11.200%).Clinical data were collected and measured,including age,height,weight,neck/waist/hip circumferences,blood pressure,comorbidities,duration of DM,and biochemical indicators.Meanwhile,neurotransmitters in the left hippocampus and left brainstem area were detected by proton magnetic resonance spectroscopy.RESULTS The HbA1c level was significantly associated with urinary microalbumin(mALB),triglyceride,low-density lipoprotein cholesterol(LDL-C),homeostasis model assessment of insulin resistance(HOMA-IR),and beta cell function(HOMA-β),N-acetylaspartate/creatine(NAA/Cr),and NAA/choline(NAA/Cho).Spearman correlation analysis showed that mALB,LDL-C,HOMA-IR and NAA/Cr in the left brainstem area were positively correlated with the level of HbA1c(P<0.05),whereas HOMA-βwas negatively correlated with the HbA1c level(P<0.05).Ordered multiple logistic regression analysis showed that NAA/Cho[Odds ratio(OR):1.608,95%confidence interval(95%CI):1.004-2.578,P<0.05],LDL-C(OR:1.627,95%CI:1.119-2.370,P<0.05),and HOMA-IR(OR:1.107,95%CI:1.031-1.188,P<0.01)were independent predictors of poor glycemic control.CONCLUSION The cerebral neurotransmitter concentrations in the left brainstem area in patients with T2DM are closely related to glycemic control,which may be the basis for the changes in cognitive function in diabetic patients. 展开更多
关键词 Type 2 diabetes mellitus Hemoglobin A1c Proton magnetic resonance spectroscopy neurotransmitterS Central neuropathy
下载PDF
Neuro faces of beneficial T cells:essential in brain,impaired in aging and neurological diseases,and activated functionally by neurotransmitters and neuropeptides 被引量:5
4
作者 Mia Levite 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第6期1165-1178,共14页
T cells are essential for a healthy life,performing continuously:immune surveillance,recognition,protection,activation,suppression,assistance,eradication,secretion,adhesion,migration,homing,communications,and addition... T cells are essential for a healthy life,performing continuously:immune surveillance,recognition,protection,activation,suppression,assistance,eradication,secretion,adhesion,migration,homing,communications,and additional tasks.This paper describes five aspects of normal beneficial T cells in the healthy or diseased brain.First,normal beneficial T cells are essential for normal healthy brain functions:cognition,spatial learning,memory,adult neurogenesis,and neuroprotection.T cells decrease secondary neuronal degeneration,increase neuronal survival after central nervous system(CNS) injury,and limit CNS inflammation and damage upon injury and infection.Second,while pathogenic T cells contribute to CNS disorders,recent studies,mostly in animal models,show that specific subpopulations of normal beneficial T cells have protective and regenerative effects in seve ral neuroinflammatory and neurodegenerative diseases.These include M ultiple Sclerosis(MS),Alzheimer’s disease,Parkinson’s disease,Amyotrophic Lateral Sclerosis(ALS),stro ke,CNS trauma,chronic pain,and others.Both T cell-secreted molecules and direct cell-cell contacts deliver T cell neuroprotective,neuro regenerative and immunomodulato ry effects.Third,normal beneficial T cells are abnormal,impaired,and dysfunctional in aging and multiple neurological diseases.Different T cell impairments are evident in aging,brain tumors(mainly Glioblastoma),seve re viral infections(including COVID-19),chro nic stress,major depression,schizophrenia,Parkinson’s disease,Alzheimer’s disease,ALS,MS,stro ke,and other neuro-pathologies.The main detrimental mechanisms that impair T cell function are activation-induced cell death,exhaustion,senescence,and impaired T cell stemness.Fo urth,several physiological neurotransmitters and neuro peptides induce by themselves multiple direct,potent,beneficial,and therapeutically-relevant effects on normal human T cells,via their receptors in T cells.This scientific field is called "Nerve-Driven Immunity".The main neurotransmitters and neuropeptides that induce directly activating and beneficial effects on naive normal human T cells are:dopamine,glutamate,GnRH-Ⅱ,neuropeptide Y,calcitonin gene-related peptide,and somatostatin.Fifth, "Personalized Adoptive Neuro-Immunotherapy".This is a novel unique cellular immunotherapy,based on the "Nerve-Driven Immunity" findings,which was recently designed and patented for safe and repeated rejuvenation,activation,and improvement of impaired and dysfunctional T cells of any person in need,by ex vivo exposure of the person’s T cells to neurotransmitters and neuropeptides.Personalized adoptive neuro-immunotherapy includes an early ex vivo personalized diagnosis,and subsequent ex vivo in vivo personalized adoptive therapy,tailo red according to the diagnosis.The Personalized Adoptive Neuro-Immunotherapy has not yet been tested in humans,pending validation of safety and efficacy in clinical trials,especially in brain tumors,chronic infectious diseases,and aging,in which T cells are exhausted and/or senescent and dysfunctional. 展开更多
关键词 AGING dopamine GLUTAMATE nerve-driven immunity neurological diseases NEUROPEPTIDES neurotransmitterS Personalized Adoptive Neuro-Immunotherapy T cells
下载PDF
Effects of a Combination of Fu Zi and Rou Gui on Intestinal Neurotransmitters and Microflora in Rats with Slow Transit Constipation
5
作者 Yuchuan LI Yuanzhe ZHANG 《Agricultural Biotechnology》 CAS 2023年第3期79-86,91,共9页
[Objectives] This study was carried out to explore the combined effects of Fu Zi(Radix Aconiti Lateralis Praeparata, the secondary root of perennial herbaceous plant Acontium carmichaeli Dehx. of family Ranunculaceae)... [Objectives] This study was carried out to explore the combined effects of Fu Zi(Radix Aconiti Lateralis Praeparata, the secondary root of perennial herbaceous plant Acontium carmichaeli Dehx. of family Ranunculaceae) and Rou Gui(Cortex Cinnamomi, the bark of Cinnamamunz cassia Presl of family Lauraceae) on intestinal neurotransmitters and microflora in rats with slow transit constipation(STC). [Methods] Experimental rats were given loperamide hydrochloride by gavage to induce STC, and then treated with Fu Zi alone, Rou Gui alone, a combination of Fu Zi and Rou Gui(2:1 w/w), and prucalopride, respectively, for 14 days. Meanwhile, the general condition, the time to first black stool and the rate of intestinal propulsion of rats in each group were observed after STC was induced and after drug treatment, and the pathological changes in rat colon were observed via hematoxylin-eosin(HE) staining, and the levels of colonic 5-hydroxytryptamine(HT), vasoactive intestinal peptide(VIP) and substance P(SP) were detected by ELISA, and the changes in intestinal flora were detected by 16S rRNA Real-time PCR. [Results] Compared with healthy rats, the time to first black stool and the rate of intestinal propulsion, colonic 5-HT and SP levels significantly decreased(p<0.01), while their colonic VIP level significantly increased(p<0.01). Compared with STC rats, the time to first black stool, the rate of intestinal propulsion, colonic 5-HT and SP levels in Fu Zi-Rou Gui(2:1) treated rats and prucalopride treated rats significantly increased(p<0.01), while their colonic VIP level significantly decreased(p<0.01). There was no significant difference in alpha diversity between healthy rats and STC rats. However, analysis on beta diversity revealed that there were differences in microflora structure and composition between them. Compared with healthy rats, the relative abundance of Firmicutes and Proteobacteria in STC rats significantly increased, while that of Bacteroidetes decreased. Compared with STC rats, the relative abundance of Proteobacteria decreased and that of Bacteroidetes and Firmicutes increased in Fu Zi-Rou Gui(2:1) treated rats;the relative abundance of Bacteroidetes and Proteobacteria decreased while that of Firmicutes increased in Fu Zi treated rats;the relative abundance of Proteobacteria decreased while that of Bacteroidetes increased in Rou Gui treated rats;the relative abundance of Firmicutes and Proteobacteria decreased while that of Bacteroidetes increased in prucalopride treated rats. The intestinal flora in rats of all groups was dominated by Lactobacillus spp. and other genera of anaerobic bacteria. Compared with healthy rats, the relative abundance of Lactobacillus spp. and Clostridium spp. in STC rats decreased, while those of Blautia spp. and Ruminococcus spp. and Allobaculum spp. increased. Compared with STC rats, the relative abundance of Lactobacillus spp. in all rats treated with drugs increased. [Conclusions] The combination of Fu Zi and Rou Gui(2:1) can effectively improve intestinal motility in STC rats by regulating intestinal microbial community and the levels of colonic neurotransmitters. 展开更多
关键词 Slow transit constipation(STC) Fu Zi-Rou Gui Intestinal motility neurotransmitterS Intestinal microflora
下载PDF
Changes in neurotransmitter levels,brain structural characteristics,and their correlation with PANSS scores in patients with firstepisode schizophrenia
6
作者 Xian-Jia Xu Tang-Long Liu +1 位作者 Liang He Ben Pu 《World Journal of Clinical Cases》 SCIE 2023年第22期5215-5223,共9页
BACKGROUND In patients with schizophrenia,the brain structure and neurotransmitter levels change,which may be related to the occurrence and progression of this disease.AIM To explore the relationships between changes ... BACKGROUND In patients with schizophrenia,the brain structure and neurotransmitter levels change,which may be related to the occurrence and progression of this disease.AIM To explore the relationships between changes in neurotransmitters,brain structural characteristics,and the scores of the Positive and Negative Symptom Scale(PANSS)in patients with first-episode schizophrenia.METHODS The case group comprised 97 patients with schizophrenia,who were evaluated using the Canadian Neurological Scale and confirmed by laboratory tests at Ningbo Mental Hospital from January 2020 to July 2022.The control group comprised 100 healthy participants.For all participants,brain structural characteristics were explored by measuring brain dopamine(DA),glutamic acid(Glu),and gamma-aminobutyric acid(GABA)levels,with magnetic resonance imaging.The case group was divided into negative and positive symptom subgroups using PANSS scores for hierarchical analysis.Linear correlation analysis was used to analyze the correlations between neurotransmitters,brain structural character istics,and PANSS scores.RESULTS Patients in the case group had higher levels of DA and lower levels of Glu and GABA,greater vertical and horizontal distances between the corpus callosum and the inferior part of the fornix and larger ventricle area than patients in the control group(P<0.05).Patients with positive schizophrenia symptoms had significantly higher levels of DA,Glu,and GABA than those with negative symptoms(P<0.05).In patients with positive schizophrenia symptoms,PANSS score was significantly positively correlated with DA,vertical and horizontal distances between the corpus callosum and the infrafornix,and ventricular area,and was significantly negatively correlated with Glu and GABA(P<0.05).In patients with negative schizophrenia symptoms,PANSS score was significantly positively correlated with DA,vertical distance between the corpus callosum and the infrafornix,horizontal distance between the corpus callosum and the infrafornix,and ventricular area,and was significantly negatively correlated with Glu and GABA(P<0.05).CONCLUSION In patients with first-episode schizophrenia,DA levels increased,Glu and GABA levels decreased,the thickness of the corpus callosum increased,and these variables were correlated with PANSS scores. 展开更多
关键词 Brain structural characteristics Negative symptoms neurotransmitters positive symptoms SCHIZOPHRENIA
下载PDF
Targeting microglial neurotransmitter receptors as a therapeutic approach for Alzheimer’s disease
7
作者 Shareen Mizari Ranja Alyas +2 位作者 Shahzoz Khan Robina Ahmad Rabia Mehmod 《Aging Communications》 2023年第2期19-25,共7页
Alzheimer’s disease(AD)is a neurodegenerative condition that disrupts nerve cell function due to the misfolding and buildup of proteins,resulting in cognitive loss and aberrant behavior.Microglia cellsare one of the ... Alzheimer’s disease(AD)is a neurodegenerative condition that disrupts nerve cell function due to the misfolding and buildup of proteins,resulting in cognitive loss and aberrant behavior.Microglia cellsare one of the crucial immune cells in the central nervous system.Depending on their activation levels,microglia cells in the degenerative phase of AD can serve either neuroprotective or neurotoxic roles.Microglia cells express several neurotransmitter receptors that play distinct functions in the degenerative progression of AD.These receptors facilitate bidirectional communication between microglia and nerve cells.The neurotransmitter receptors on microglia cells can mediate or affect the neuroprotective or toxic effects of microglia cells,thereby affecting AD pathology.This paper focuses on the gamma-aminobutyric acid,glutaminergic,cannabinoid,cholinergic,and adrenergic receptors on microglia cells and their relationship with AD.Understanding how neurotransmitter receptors on microglia function in AD will be crucial for identifying potential treatment targets. 展开更多
关键词 MICROGLIA neurotransmitter receptor Alzheimer’s disease
下载PDF
肠道菌群影响阿尔茨海默病病理机制的研究进展 被引量:1
8
作者 宋博雅 刘军 郝琳 《生理科学进展》 CAS 北大核心 2024年第1期28-33,共6页
阿尔茨海默病(Alzheimer's disease,AD)是一种渐进性神经退行性病变,目前其发病机制尚未明晰。新近研究发现,肠道菌群可通过影响中枢神经系统功能而影响宿主的认知与行为,可能是治疗神经退行性疾病的重要靶标。肠道菌群稳态失调与... 阿尔茨海默病(Alzheimer's disease,AD)是一种渐进性神经退行性病变,目前其发病机制尚未明晰。新近研究发现,肠道菌群可通过影响中枢神经系统功能而影响宿主的认知与行为,可能是治疗神经退行性疾病的重要靶标。肠道菌群稳态失调与肠壁生理屏障破坏可诱发外周系统炎症反应,通过介导神经递质及菌群分泌物等生理活性物质的释放而影响神经发生、神经元间的信号通讯,导致中枢神经发生炎症反应,协同作用加剧神经损伤进程,推动AD病理发展。因此,深入探究肠道菌群稳态失调影响AD发生发展的可能机制可为防治和缓解AD提供新的视角,为促进健康老龄化提供新策略。 展开更多
关键词 肠道菌群 阿尔茨海默病 炎症 神经炎症 神经递质
下载PDF
疏肝理气养血方联合氢溴酸西酞普兰治疗卒中后失眠伴抑郁老年患者的疗效观察及对睡眠质量和神经递质的影响
9
作者 徐明超 樊书领 +1 位作者 李尽义 任应国 《中国合理用药探索》 CAS 2024年第1期98-103,共6页
目的:观察疏肝理气养血方联合氢溴酸西酞普兰治疗卒中后失眠伴抑郁老年患者的疗效及对睡眠质量和神经递质的影响。方法:选取2021年5月~2023年2月某院收治的114例卒中后失眠伴抑郁的老年患者为研究对象,采用随机数字表法分为对照组与观察... 目的:观察疏肝理气养血方联合氢溴酸西酞普兰治疗卒中后失眠伴抑郁老年患者的疗效及对睡眠质量和神经递质的影响。方法:选取2021年5月~2023年2月某院收治的114例卒中后失眠伴抑郁的老年患者为研究对象,采用随机数字表法分为对照组与观察组,每组57例。对照组给予氢溴酸西酞普兰片,观察组在对照组治疗基础上加用疏肝理气养血方。比较两组神经递质的水平[5-羟色胺(5-HT)、P物质(SP)、甘氨酸、γ-氨基丁酸],评估两组美国国立卫生院卒中量表(NIHSS)评分、匹兹堡睡眠质量指数(PSQI)评分、中医症状评分、汉密尔顿抑郁量表(HAMD)评分、日常生活能力(ADL)评分的差异。比较两组临床治疗总有效率并记录治疗期间两组不良反应的发生情况。结果:治疗后,两组患者5-HT、甘氨酸、γ-氨基丁酸均较治疗前升高,且观察组高于对照组(P<0.05);SP较治疗前降低,且观察组低于对照组(P<0.05);NIHSS评分、PSQI评分、HAMD评分、中医症状评分均较治疗前降低,且观察组PSQI评分、HAMD评分、中医症状评分低于对照组(P<0.05);ADL评分较治疗前升高,且观察组高于对照组(P<0.05)。治疗后,观察组临床治疗总有效率(91.23%)高于对照组(77.19%,P<0.05)。治疗期间两组患者不良反应总发生率比较无统计学差异。结论:疏肝理气养血方联合氢溴酸西酞普兰可有效改善卒中后失眠伴抑郁老年患者的抑郁和失眠症状,提高睡眠质量,调节神经递质的表达,提高临床疗效,且不增加不良反应的发生风险。 展开更多
关键词 疏肝理气养血方 氢溴酸西酞普兰 抑郁 卒中 失眠 神经递质
下载PDF
4T1乳腺癌细胞株接种联合慢性束缚应激诱导乳腺癌合并抑郁小鼠模型构建探索
10
作者 刘燕 彭梦薇 +4 位作者 刘高源 杨铁柱 张文娴 吴耀松 陈玉龙 《中国比较医学杂志》 CAS 北大核心 2024年第3期36-44,50,共10页
目的研究4T1乳腺癌细胞株接种联合慢性束缚应激方法构建乳腺癌合并抑郁症小鼠模型核心行为症状、生物学指标、病理学等改变。方法BABL/c小鼠随机分为正常(Control)组、束缚(Stress)组、移植瘤(Tumor)组和束缚移植瘤(Stress+Tumor,S+T)组... 目的研究4T1乳腺癌细胞株接种联合慢性束缚应激方法构建乳腺癌合并抑郁症小鼠模型核心行为症状、生物学指标、病理学等改变。方法BABL/c小鼠随机分为正常(Control)组、束缚(Stress)组、移植瘤(Tumor)组和束缚移植瘤(Stress+Tumor,S+T)组,将4T1细胞株接种于Tumor和S+T组小鼠腋下,待成瘤后,给予Stress和S+T组小鼠束缚应激21 d。造模期间监测各组小鼠体重、摄食量。实验结束后,采用糖水偏好、旷场、高架十字迷宫、强迫游泳等试验评价各组小鼠抑郁样行为。小鼠处死后,测量小鼠瘤体重量和体积;采用ELISA方法检测各组小鼠血清肿瘤标志物糖类抗原(CA199)、癌胚抗原(CEA)、血管内皮生长因子(VEGF)以及相关神经递质5-羟色胺(5-HT)、去甲肾上腺素(NE)、皮质酮(CORT)的含量;运用HE染色法观察小鼠肿瘤和海马组织病理学改变。结果S+T组小鼠体重、摄食量显著降低,瘤体重量和体积明显增大,血清肿瘤标志物(CA199、CEA、VEGF)水平显著升高,快感和对新环境的探索欲望减弱,紧张和绝望行为显著增强,血清神经递质5-HT和NE水平显著降低,CORT水平显著升高;另外肿瘤组织细胞排列松散,间质减少,病理性核分裂象增多,海马CA3区神经元细胞排列和形态紊乱,核内空泡化样改变明显。结论4T1乳腺癌细胞株接种联合慢性束缚应激诱导的乳腺癌合并抑郁小鼠模型出现了乳腺癌和抑郁症双重典型症状和生物学指标改变,可为乳腺癌合并抑郁实验研究提供较好的模型参考。 展开更多
关键词 乳腺癌合并抑郁 移植瘤 慢性束缚应激 肿瘤标志物 神经递质 行为学
下载PDF
低频经颅磁刺激联合早期康复训练在伴智力低下孤独症谱系障碍患儿中的应用
11
作者 王贝贝 张少华 +1 位作者 高芳 赵梦姿 《河南医学研究》 CAS 2024年第14期2592-2595,共4页
目的探究低频经颅磁刺激(TMS)联合早期康复训练治疗伴智力低下孤独症谱系障碍(ASD)患儿的效果。方法选取南阳市第一人民医院2018年2月至2022年9月收治的104例伴智力低下ASD患儿,按随机数字表法分成两组,每组52例。以接受早期康复训练的5... 目的探究低频经颅磁刺激(TMS)联合早期康复训练治疗伴智力低下孤独症谱系障碍(ASD)患儿的效果。方法选取南阳市第一人民医院2018年2月至2022年9月收治的104例伴智力低下ASD患儿,按随机数字表法分成两组,每组52例。以接受早期康复训练的52例伴智力低下ASD患儿列为B组,以接受低频TMS联合早期康复训练的52例伴智力低下ASD患儿列为A组。对比两组治疗前后孤独症行为评定量表(ABC)评分、中国韦氏儿童智力量表(C-WISC)评分、儿童感觉统合评定量表(CSIRS)评分、事件相关电位(ERP)P3潜伏期、波幅、神经递质[γ-氨基丁酸(GABA)、谷氨酸(GLU)、5-羟色胺(5-HT)、脑源性神经营养因子(BDNF)]水平。结果治疗6个月后A组感觉、交往、躯体运动、语言、生活自理评分较B组低(P<0.05);治疗6个月后A组言语智商、操作智商及总智商评分较B组高(P<0.05);治疗6个月后A组学习能力、触觉防御、本体感觉、前庭失衡评分较B组高(P<0.05);治疗6个月后A组ERP P3潜伏期较B组低,波幅较B组高(P<0.05);治疗6个月后A组血清GLU、5-HT、BDNF水平较B组低,血清GABA水平较B组高(P<0.05)。结论低频TMS联合早期康复训练治疗伴智力低下ASD患儿可进一步改善行为能力,提升智力水平,改善感觉统合能力,维持中枢神经系统内环境平衡。 展开更多
关键词 智力低下 孤独症谱系障碍 神经递质
下载PDF
补肾活血疏肝汤联合西药治疗帕金森病疗效及作用机制
12
作者 黄宇 陈绚 《河北中医》 2024年第4期574-577,582,共5页
目的观察补肾活血疏肝汤联合西药治疗帕金森病的临床效果及作用机制。方法选择2021年1月至2022年5月收治的96例帕金森病患者为研究对象,按照随机数字表法分为2组,对照组48例予常规西药治疗,治疗组48例在对照组的基础上联合补肾活血疏肝... 目的观察补肾活血疏肝汤联合西药治疗帕金森病的临床效果及作用机制。方法选择2021年1月至2022年5月收治的96例帕金森病患者为研究对象,按照随机数字表法分为2组,对照组48例予常规西药治疗,治疗组48例在对照组的基础上联合补肾活血疏肝汤治疗。2组均治疗3个月后统计疗效,比较2组治疗前后神经递质[包括血清5-羟色胺(5-HT)、去甲肾上腺素(NE)及多巴胺(DA)]、神经营养因子[包括血清神经生长因子(NGF)、脑源性神经营养因子(BDNF)及胶质细胞源性神经营养因子(GDNF)]、生活质量[采用帕金森患者的生活质量问卷(PDQ-39)进行评价,包括日常生活状况、精神健康、屈辱感、认知、交流、社会支持、身体活动及身体不适]及病情严重程度[采用世界运动障碍病学会新版帕金森病综合评价量表(MDS-UPDRS)中非运动症状、日常生活活动及运动症状评分进行评价]变化。结果治疗组总有效率95.83%(46/48),对照组总有效率77.08%(37/48),治疗组总有效率高于对照组(P<0.05)。与本组治疗前比较,2组治疗后神经递质血清5-HT、NE及DA水平均升高(P<0.05),且治疗组治疗后血清5-HT、NE及DA水平均高于对照组(P<0.05)。与本组治疗前比较,2组治疗后神经营养因子血清NGF、BDNF及GDNF水平均升高(P<0.05),且治疗组治疗后血清NGF、BDNF及GDNF水平均高于对照组(P<0.05)。与本组治疗前比较,2组治疗后PDQ-39日常生活状况、精神健康、屈辱感、认知、交流、社会支持、身体活动及身体不适评分均降低(P<0.05),且治疗组治疗后PDQ-39各项评分均低于对照组(P<0.05)。与本组治疗前比较,2组治疗后MDS-UPDRS非运动症状、日常生活活动及运动症状评分均降低(P<0.05),且治疗组治疗后MDS-UPDRS非运动症状、日常生活活动及运动症状评分均低于对照组(P<0.05)。结论补肾活血疏肝汤联合西药治疗帕金森病临床疗效确切,可有效提高患者生活质量,改善临床症状,其作用机制可能与提高5-HT、NE及DA水平,纠正神经递质网络紊乱,提高NGF、BDNF及GDNF水平,促进神经细胞修复有关。 展开更多
关键词 帕金森 神经递质 神经营养因子 中西医结合疗法
下载PDF
以认知神经科学为导向的课堂教学环境构建机理与实践分析
13
作者 刘涛 黄媛 +2 位作者 蒋燕妮 李轲 高贵 《军事高等教育研究》 2024年第1期103-108,共6页
针对雷达系统课程内容多、难度大等问题,从认知神经科学理论出发,阐述了神经递质与深度学习之间的关系,揭示了课堂教学本质并给出了神经学解释,提出了以诱导神经递质分泌为牵引、以人脑协同认知为目标的课堂教学环境构建方案,体现了“... 针对雷达系统课程内容多、难度大等问题,从认知神经科学理论出发,阐述了神经递质与深度学习之间的关系,揭示了课堂教学本质并给出了神经学解释,提出了以诱导神经递质分泌为牵引、以人脑协同认知为目标的课堂教学环境构建方案,体现了“学为中心”的教育理念。教学环境由日常舒适环境、教室舒适环境、内容舒适环境、好奇挑战环境和自主舒适环境五部分构成。课堂教学环境的构建使得课程从舒适区边缘展开突破,符合脑科学机理,培养了学员以“新旧知识关系建立”为核心的自主学习能力。 展开更多
关键词 认知神经 神经递质 多巴胺 雷达系统 自学能力 环境
下载PDF
高-低频重复经颅磁刺激联合应用对脑梗死偏瘫患者神经递质及运动功能的影响
14
作者 李桂英 陈国芳 傅新民 《中华保健医学杂志》 2024年第1期26-29,共4页
目的探讨高-低频重复经颅磁刺激联合应用对脑梗死偏瘫患者神经递质及运动功能的影响。方法选取2019年8月~2022年8月徐州市中心医院收治的脑梗死偏瘫患者105例,随机数表法分为低频组、高频组和联合组,各35例。在常规康复治疗基础上,低频... 目的探讨高-低频重复经颅磁刺激联合应用对脑梗死偏瘫患者神经递质及运动功能的影响。方法选取2019年8月~2022年8月徐州市中心医院收治的脑梗死偏瘫患者105例,随机数表法分为低频组、高频组和联合组,各35例。在常规康复治疗基础上,低频组给予健侧低频rTMS治疗,高频组接受患侧高频rTMS治疗,联合组同时接受健侧低频和患侧高频rTMS治疗。比较各组患者血清神经递质[5-羟色胺(5-HT)、多巴胺(DA)、脑源性神经营养因子(BDNF)]水平、神经传导功能[运动诱发电位(MEP)潜伏期、运动传导时间(CMCT)]及肢体运动功能[Fugl-Meyer运动功能量表(FMA)评分、Berg平衡量表(BBS)评分、Barthel指数]差异。结果治疗前,3组患者血清5-HT、DA及BDNF水平差异均无统计学意义(P>0.05)。治疗后,3组患者血清5-HT、DA、BDNF水平显著提高,其中联合组明显高于低频组、高频组,差异有统计学意义(F=12.038、16.356、9.388,P<0.05)。治疗前,3组患者FMA评分、BBS评分、Barthel指数差异均无统计学意义(P>0.05)。治疗后,3组患者FMA评分、BBS评分、Barthel指数显著提高,其中联合组明显高于低频组、高频组,差异有统计学意义(F=6.562、4.971、6.604,P<0.05)。治疗前,3组患者MEP潜伏期、CMCT参数差异均无统计学意义(P>0.05)。治疗后,3组患者MEP潜伏期、CMCT均缩短,且联合组MEP潜伏期、CMCT小于低频组、高频组,差异有统计学意义(F=10.234、9.615,P<0.05)。结论高-低频联合rTMS能刺激神经递质释放,促进脑梗死偏瘫患者肢体运动功能恢复,效果优于单一频率rTMS治疗,可作为临床有效的辅助治疗手段。 展开更多
关键词 脑梗死 偏瘫 重复经颅磁刺激 运动功能 神经递质 血流动力学
下载PDF
针刺捻转补泻手法对自发性高血压大鼠神经递质及炎症因子的影响
15
作者 张静 刘继鹏 +3 位作者 岳炳南 高辛瑜 张琳 刘清国 《中国中医急症》 2024年第6期959-962,981,共5页
目的通过观察针刺捻转补泻手法对自发性高血压大鼠(SHR)下丘脑室旁核(PVN)中神经递质γ-氨基丁酸(GABA)、谷氨酸(Glu)含量以及血清中炎症因子白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平表达的影响,探寻针刺调控血压的作用机制。... 目的通过观察针刺捻转补泻手法对自发性高血压大鼠(SHR)下丘脑室旁核(PVN)中神经递质γ-氨基丁酸(GABA)、谷氨酸(Glu)含量以及血清中炎症因子白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平表达的影响,探寻针刺调控血压的作用机制。方法27只雄性SHR大鼠随机分配到补法组、泻法组和模型组中。9只Wistar-Kyoto(WKY)大鼠作为空白组。空白组和模型组只进行捉抓固定不做针刺干预,补法组和泻法组均取双侧的太冲穴进行针刺干预。各组每日上午干预1次,周期为14 d,2周之间休息1 d。于针刺第0、3、7、14日定期测量大鼠尾动脉收缩压并记录。实验第14日取材,采用ELISA法检测大鼠PVN中GABA、Glu的含量,以及检测血清中炎症因子IL-6、TNF-α的含量,最后使用HE染色法观察PVN组织病理学改变。结果与模型组相比,补法组和泻法组均能显著降低SHR大鼠血压(P<0.01),且泻法组降压效果更为显著(P<0.05)。针刺后,与模型组相比,补法组和泻法组PVN组织中GABA含量显著增加,Glu含量显著降低(均P<0.01);补法组和泻法组血清中IL-6、TNF-α水平相比模型组显著下降(P<0.05或P<0.01)。HE染色结果显示:与模型组相比,补法组和泻法组可改善病变情况,细胞总数增多。结论针刺捻转补泻手法可明显降低SHR大鼠血压,且捻转泻法降压效果更为显著,其作用机制可能与PVN中神经递质GABA含量升高、Glu含量降低,以及炎症因子IL-6、TNF-α水平下降相关。 展开更多
关键词 高血压 针刺 捻转补泻手法 下丘脑室旁核 神经递质 炎症因子 自发性高血压大鼠
下载PDF
基于经络辨治对改善失眠患者神经递质的数据挖掘
16
作者 宋晓容 林洪 +2 位作者 刘卓超 程波敏 朱艳萍 《深圳中西医结合杂志》 2024年第5期14-19,共6页
目的:采用数据挖掘的方法,探索运用经络理论在调节失眠患者神经递质方面的辨治规律。方法:检索2003年1月至2023年5月期间在中国知网数据库(CNKI)、万方数据知识服务平台、维普数据库等数据库中关于以经络理论辨证论治失眠患者后,针对改... 目的:采用数据挖掘的方法,探索运用经络理论在调节失眠患者神经递质方面的辨治规律。方法:检索2003年1月至2023年5月期间在中国知网数据库(CNKI)、万方数据知识服务平台、维普数据库等数据库中关于以经络理论辨证论治失眠患者后,针对改善失眠患者神经递质变化的相关文献,提取纳入文献的取穴处方,对高频穴位进行频次分析,并进行归经,关联分析及聚类分析,对所涉及的经络进行网络可视化分析。结果:本研究共纳入文献41篇,其中穴位处方41首。涉及穴位54个,其中使用频次≥3次的穴位27个,共涉及12条经脉。使用频次最高的穴位为百会,穴位归经后使用频次最高的经络为督脉;关联分析显示高频使用穴位关联程度较高的穴位为照海、百会、神门、三阴交,高频使用经络之间的关联度最高的为足厥阴肝经→足太阳膀胱经,相关性较好的经络为足厥阴肝经、足太阳膀胱经、督脉、足少阳胆经、手少阳三焦经。高频穴位聚类可得到核心取穴组合7个。结论:经络理论辨治失眠患者,核心穴位处方为百会、神门、三阴交,治疗以督脉上穴位相关性最强,通过不同的穴位处方组合,可以改善患者的神经递质,从而达到改善睡眠的效果。 展开更多
关键词 失眠 经络辨治 神经递质 数据挖掘
下载PDF
美金刚联合多奈哌齐治疗阿尔茨海默病患者的效果
17
作者 李颖 李慧 +1 位作者 李海平 李薇 《中国民康医学》 2024年第13期37-40,共4页
目的:观察美金刚联合多奈哌齐治疗阿尔茨海默病(AD)患者的效果。方法:选取2020年4月至2023年4月北华大学附属医院收治的82例AD患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各41例。对照组予以多奈哌齐治疗,观察组在对照... 目的:观察美金刚联合多奈哌齐治疗阿尔茨海默病(AD)患者的效果。方法:选取2020年4月至2023年4月北华大学附属医院收治的82例AD患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各41例。对照组予以多奈哌齐治疗,观察组在对照组基础上联合美金刚治疗,两组均治疗8周。比较两组临床疗效,治疗前后认知功能[简易精神状态检查量表(MMSE)、阿尔茨海默病评定量表-认知部分(ADAS-cog)]评分、日常生活活动能力[日常生活活动能力量表(ADL)]评分、神经递质指标[5-羟色胺(5-HT)、多巴胺(DA)、乙酰胆碱(Ach)]水平,以及不良反应发生率。结果:观察组治疗总有效率为95.12%(39/41),高于对照组的78.05%(32/41),差异有统计学意义(P<0.05);治疗后,观察组MMSE、ADL评分高于对照组,ADAS-cog评分低于对照组,差异均有统计学意义(P<0.05);治疗后,观察组5-HT、DA、Ach水平均高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:美金刚联合多奈哌齐治疗AD患者可提高治疗总有效率、日常生活活动能力评分和神经递质指标水平,改善认知功能评分,效果优于单纯多奈哌齐治疗。 展开更多
关键词 阿尔茨海默病 美金刚 多奈哌齐 认知功能 日常生活活动能力 神经递质 不良反应
下载PDF
选择性痔上黏膜切除吻合术治疗Ⅲ度混合痔的5-HT、PGE2及IL-6水平变化及疗效
18
作者 张智航 陈昊 赵德余 《分子诊断与治疗杂志》 2024年第3期498-502,共5页
目的 分析选择性痔上黏膜切除吻合术(TST)治疗Ⅲ度混合痔的神经递质及5-羟色胺(5-HT)、前列腺素E2(PGE2)及白介素-6(IL-6)水平变化及临床疗效。方法 本研究采用单中心回顾性研究方法,收集2020年5月至2023年1月大连市中心医院收治的108... 目的 分析选择性痔上黏膜切除吻合术(TST)治疗Ⅲ度混合痔的神经递质及5-羟色胺(5-HT)、前列腺素E2(PGE2)及白介素-6(IL-6)水平变化及临床疗效。方法 本研究采用单中心回顾性研究方法,收集2020年5月至2023年1月大连市中心医院收治的108例Ⅲ度混合痔患者,依据治疗方式分为对照组[n=53,予吻合器痔上黏膜环切术(PPH)治疗]和观察组(n=55,予TST治疗)。对比两组临床疗效、围手术期指标(手术时长、术中出血量、住院时间、术后首次排便时间、术后卧床时间)、5-HT、PGE2、炎性因子[IL-6、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)水平]、肛肠动力学指标[直肠感知阈值(RSTV)、肛管静息压(RASP)、直肠最大容量阈值(RMTV)]及并发症发生率。结果 观察组临床总有效率(94.55%)比对照组(81.13%)高,差异有统计学意义(P<0.05);观察组术后首次排便时间、手术时长、术后卧床时间及住院时间比对照组短,术中出血量比对照组少,差异有统计学意义(P<0.05);治疗后,两组5-HT、PGE2水平均下降,且观察组比对照组低,差异有统计学意义(P<0.05);治疗后,两组IL-6、CRP、TNF-α水平均下降,且观察组比对照组低,差异有统计学意义(P<0.05);治疗后,观察组RSTV、RMTV比对照组高,RASP比对照组低,差异有统计学意义(P<0.05);观察组并发症总发生率(7.28%)比对照组(20.75%)低,差异有统计学意义(P<0.05)。结论 采用TST治疗Ⅲ度混合痔患者疗效更显著,明显改善了患者围术期指标,降低了患者5-HT、PGE2及IL-6、TNF-α、CRP炎性因子水平,降低术后并发症发生率,利于术后恢复。 展开更多
关键词 选择性痔上黏膜切除吻合术 混合痔 神经递质及5-羟色胺 前列腺素E2 白介素-6
下载PDF
基于5-HT-BDNF轴研究针刺联合柴胡疏肝方对大鼠缺血再灌注脑损伤的保护作用及机制
19
作者 陈国健 潘锦涛 伍彩云 《中国医药科学》 2024年第9期8-12,17,共6页
目的探讨针刺联合柴胡疏肝方对脑卒中大鼠脑功能的保护活动和机制。方法构建大鼠大脑中动脉闭塞(MCAO)模型,针刺联合柴胡疏肝方治疗前后进行脑功能评价;酶联免疫吸附试验检测各组大鼠脑组织中单胺类神经递质5-羟色胺(5-HT)、多巴胺(DA)... 目的探讨针刺联合柴胡疏肝方对脑卒中大鼠脑功能的保护活动和机制。方法构建大鼠大脑中动脉闭塞(MCAO)模型,针刺联合柴胡疏肝方治疗前后进行脑功能评价;酶联免疫吸附试验检测各组大鼠脑组织中单胺类神经递质5-羟色胺(5-HT)、多巴胺(DA)和去甲肾上腺素(NE)的表达水平;免疫印迹法检测各组大鼠脑组织中脑源性神经营养因子(BDNF)蛋白表达水平。结果相比于针刺或柴胡疏肝方单独治疗,针刺联合柴胡疏肝方对大鼠脑卒中模型的脑功能损伤具有更好的保护作用;针刺联合柴胡疏肝方能够上调大鼠脑组织中单胺类递质5-HT、DA和NE的表达;针刺联合柴胡疏肝方能够上调大鼠脑组织中BDNF蛋白表达。结论针刺联合柴胡疏肝方对大鼠缺血再灌注脑损伤具有更好的保护作用,其可能与单胺类神经递质的相互作用以及上调BDNF蛋白的表达有关。 展开更多
关键词 脑缺血再灌注 针刺 柴胡疏肝方 单胺类神经递质 脑源性神经营养因子
下载PDF
Na^(+)/K^(+)-ATPase:ion pump,signal transducer,or cytoprotective protein,and novel biological functions 被引量:1
20
作者 Songqiang Huang Wanting Dong +1 位作者 Xiaoqian Lin Jinsong Bian 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第12期2684-2697,共14页
Na^(+)/K^(+)-ATPase is a transmembrane protein that has important roles in the maintenance of electrochemical gradients across cell membranes by transporting three Na^(+)out of and two K^(+)into cells.Additionally,Na^... Na^(+)/K^(+)-ATPase is a transmembrane protein that has important roles in the maintenance of electrochemical gradients across cell membranes by transporting three Na^(+)out of and two K^(+)into cells.Additionally,Na^(+)/K^(+)-ATPase participates in Ca^(2+)-signaling transduction and neurotransmitter release by coordinating the ion concentration gradient across the cell membrane.Na^(+)/K^(+)-ATPase works synergistically with multiple ion channels in the cell membrane to form a dynamic network of ion homeostatic regulation and affects cellular communication by regulating chemical signals and the ion balance among different types of cells.Therefo re,it is not surprising that Na^(+)/K^(+)-ATPase dysfunction has emerged as a risk factor for a variety of neurological diseases.However,published studies have so far only elucidated the important roles of Na^(+)/K^(+)-ATPase dysfunction in disease development,and we are lacking detailed mechanisms to clarify how Na^(+)/K^(+)-ATPase affects cell function.Our recent studies revealed that membrane loss of Na^(+)/K^(+)-ATPase is a key mechanism in many neurological disorders,particularly stroke and Parkinson's disease.Stabilization of plasma membrane Na^(+)/K^(+)-ATPase with an antibody is a novel strategy to treat these diseases.For this reason,Na^(+)/K^(+)-ATPase acts not only as a simple ion pump but also as a sensor/regulator or cytoprotective protein,participating in signal transduction such as neuronal autophagy and apoptosis,and glial cell migration.Thus,the present review attempts to summarize the novel biological functions of Na^(+)/K^(+)-ATPase and Na^(+)/K^(+)-ATPase-related pathogenesis.The potential for novel strategies to treat Na^(+)/K^(+)-ATPase-related brain diseases will also be discussed. 展开更多
关键词 ANTIBODY biological functions cellular communication electrochemical gradient ion balance ion channels Na^(+)/K^(+)-ATPase neurological diseases neurotransmitter release signal transduction
下载PDF
上一页 1 2 157 下一页 到第
使用帮助 返回顶部